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Abstract
OBJECTIVE: To investigate the gastroprotective
effects of Acanthopanax senticosus leaves (ASLs)
extrusion on acute gastric mucosal lesion in rats
induced by compound 48 / 80 (C48 / 80).
METHODS: Rats were divided into six groups:
normal; C48/80-induced gastric lesion control;
gastric lesion positive control (famotidine 4 mg/
kg); gastric lesion administered with two levels of
extruded ASLs (ASLE, 40 and 200 mg/kg); and
gastric lesion treated with ASLs (ASL 200 mg/kg).
Mucus secretion / damage was determined by
immunohistological staining. Immunofluorescence
and western blotting were performed to determine
gastric mucosal Bax and Bcl-2 expression. Gastric
mucosal oxidative-stress-related enzymes and
malondialdehyde were determined.
RESULTS: C48/80-induced mucus depletion and
inflammation in the gastric mucosa were
significantly attenuated by ASLs. The increased
serum serotonin and histamine concentrations in
C48/80-treated rats were also attenuated by ASLs.
Gastric mucosal Bax protein expression was inc-
reased and Bcl-2 expression was decreased after
C48/80 treatment, and ASLs ameliorated Bax and
Bcl-2 expression. The extrusion process sign-
ificantly augmented the effects of ASLs in a dose-
dependent manner. ASLEs at 200 mg/kg nor-
malized mucus damage / secretion, C48 / 80-
induced increases of mucosal myeloperoxidase
activity (index of inflammation), xanthine oxidase,
and malondialdehyde content (index of lipid per-
oxidation). The effects of ASLs on Bax and Bcl-2
expression were also enhanced by extrusion.
Furthermore, these effects of ASLEs at 200 mg/kg
were similar to those of famotidine, a histamine
H2-receptor antagonist commonly used to treat
gastric ulcers.
CONCLUSION: ASLEs prevented acute gastric
mucosal lesion progression induced by C48/80,
possibly by inducing mucus production, and
reduced inflammation and oxidative stress in
gastric mucosa through an anti-apoptotic mec-
hanism.
© 2016 JTCM. All rights reserved.
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INTRODUCTION
Acanthopanax senticosus (AS), also called Siberian
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ginseng, is a widely used traditional medicine in East
Asia. Since the first phytochemical and
pharmacological studies of AS by Brekhman and his
group in Russia in 1969,1 the roots and stem barks of
AS have been extensively studied, suggesting a variety
of properties such as antibacterial, anti-inflammatory,
anti-hepatitis, anti-hyperglycemic, anti-oxidant,
immunostimulatory, hypocholesterolemic, and
radioprotective effects.2,3 However, its medical use has
depleted its resources. Therefore, there is a current
trend to develop a method to use the leaves for medical
purposes. The leaves of this plant contain di- and
triterpenoids, saponins, and flavonoids,4-6 and recent
pharmacological investigations of AS leaves (ASLs)
report anti-oxidant, anti-diabetic, and anti-platelet
aggregating activities.7-9
Gastric ulcers are common worldwide, and affect
5%-10% of people during their lifetime. Therapy for
gastric ulcers includes control of acid secretion or
histamine H2 receptor blockers such as famotidine, as
well as reversal of mucosal inflammation. The
anti-inflammatory effects of ASLs are suggested by
their nitric oxide scavenging activity and their
suppression of lipopolysaccharide-induced nitric oxide
synthesis.10,11
Extrusion is one of the most common industrial
processes used to enhance the digestibility and
bioavailability of food nutrients. Several studies have
reported that extrusion has the potential to increase the
yields of the effective components, such as saponins,
ginsenosides, and flavonoids;12,13 therefore, the
extrusion process could be an interesting alternative to
functional foods. The present study examined the
protective effect of ASLs and extruded ASLs (ASLEs)
on acute gastric mucosal lesions induced by compound
48 / 80 (C48/80) in rats.
MATERIALS ANDMETHODS
Preparation of plant samples
The leaves of Acanthopanax senticosus var. subinermis
(ASLs) were collected in June 2008 from Yesan city,
Korea. The air-dried and coarsely powdered ASLs were
extruded using a twin-screw extruder (THK 31T;
Inchon Machinery, Inchon, Korea). The extruder was
operated at a feed rate of 110 g/min with a screw speed
of 200 rpm, pressure of 5 bars, and temperature of
150℃. Samples were dried, soaked in hot water for 48
h, filtered through a 0.45-μm filter (Osmonics,
Minnetonka, MN, USA), and lyophilized. The yields
after vacuum evaporation were 9.7 and 10.4% for
ASLs and ASLEs, respectively.
Animals and gastric mucosal lesion induction by
C48/80
Six-week-old male Wistar rats were purchased from
Samtako (Osan, Korea) and housed at a controlled
temperature (23 ± 2) ℃ and relative humidity (60 ±
5) % , and 12-h light/dark cycle (7:00-19:00 h) with
free access to water. The experiment was reviewed and
approved by the Animal Care and Research Ethics
Committee of Semyung University (smecae08-12-03).
Rats were divided into six groups of 10: normal (no
gastric lesion and administered distilled water); gastric
lesion control (administered distilled water); gastric
lesion positive control (administered 4 mg/kg
famotidine; Nelson Korea, Seoul, Korea); gastric lesion
administered with two levels of ASLEs (40 and
200 mg/kg); and gastric lesion treated with ASLs
(200 mg/kg). The animals were maintained with free
access to rat chow, and famotidine, ASL and ASLE
extracts were orally administered via a stomach tube.
Five days after administration, C48/80 (0.75 mg/kg,
Sigma-Aldrich, Rochester, NY, USA), dissolved in
saline, was intraperitoneally injected to rats after
fasting for 24 h. Normal control rats received saline
injection. The animals were sacrificed by decapitation
under ether anesthesia 3 h after C48/80 injection, and
blood samples were obtained from the cervical wound.
Histological analysis
The isolated stomachs were cut open along the greater
curvature and washed in ice-cold saline. Part of the
mucosa was fixed with 10% formalin solution, and
routinely processed for embedding in paraffin wax.
Five-micrometer-thick sections were cut and stained
with Periodic acid-Schiff (PAS) staining16 to observe
mucus secretion. Mucosal damage was analyzed with
an image analyzer (Image-Pro Plus; Media Cybernetics,
Rockville, MD, USA), and expressed as a percentage of
PAS-negative mucosal surface.
The measurement of gastric mucosal adherent mucus
is another indicator of gastric mucus secretion, and was
assayed using Alcian blue staining.17 A 50-mm2 (~8
mm diameter) portion of the glandular region of the
stomach was excised with a scalpel, and soaked in
0.1% Alcian blue dissolved in 0.16 M sucrose buffered
with 0.05 M sodium acetate (pH 5.8) for 2 h. The
unbound dye was removed and dye complex with
mucus was extracted using 30% docusate sodium salt
(Sigma-Aldrich) for 2 h. After centrifugation at 2060 ×g
for 10 min, the optical density (OD) of the Alcian blue
solution was measured at 620 nm, and calculated using
the calibration curve. The adherent gastric mucosal
mucus was expressed as the percentage of the Alcian
blue adhering to the gastric mucosal surface of the
gastric lesion control group.
Immunofluorescence analysis
Five-micrometer-thick sections were cut and mounted
on glass slides. The immunofluorescence analysis was
performed with mouse monoclonal anti-Bax antibody
and rabbit monoclonal anti-Bcl-2 antibody (Santa
Cruz Biotechnology, Dallas, TX, USA), and
fluorescein-isothiocyanate-conjugated anti-mouse and
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anti-rabbit IgG antibodies, respectively (Sigma
Chemical Co., St Louis, MO, USA). The nuclei were
counterstained with 1 μg/mL propidium iodide (Sigma
Chemical Co., St Louis, MO, USA). The fluorescence
images were obtained with a laser confocal microscope
(Fluoview FV1000; Olympus, Tokyo, Japan). OD was
measured using Biold software (Vilber Lourmat,
Marne-la-Vallée Cedex, France).
Laser micro-dissection (LMD) and protein extraction
For LMD, a 10-μm-thick section prepared from the
same tissue block was attached to glass slides. Sixteen
fragments of gastric tissues were collected in a 0.5-mL
tube cap using an ION LMD (Jungwoo F&B Co.,
Bucheon, Korea). Protein extraction was performed as
previously described.18 Tissue fragments were
deparaffinized and boiled at 100 ℃ in Tris-HCl buffer,
pH 8, containing 2% sodium dodesyl sulfate (SDS).
Protein concentrations were measured using a DC
Protein Assay kit (Bio-Rad, Hercules, CA, USA).
Western blotting
Protein was fractionated by 10% SDS-polyacrylamide
gel electrophoresis, and transferred onto polyvinylidene
difluoride (PVDF) membranes. Membranes were
blocked, incubated with primary antibodies (mouse
anti-Bax and rabbit anti-Bcl2 antibodies), and further
incubated with anti-mouse and anti-rabbit IgG
secondary antibodies conjugated with horseradish
peroxidase. Membranes were filmed with a
chemiluminescent imaging system (Fusion SL2; Vilber
Lourmat, Marne-la-Vallée, France), and analyzed using
Bio1d software (Vilber Lourmat, France).
Gastric mucosal enzymes and components
Part of the gastric mucosal tissue was homogenized and
centrifuged for 10 min at 9000 ×g and the supernatant
was used for malondialdehyde (MDA),
myeloperoxidase (MPO), and xanthine oxidase (XO)
determination. The MDA level was determined by
thiobarbituric acid reactive substance (TBARS)
colorimetric assay (Synergy2; BioTek, Winooski, VT,
USA). Gastric mucosal MPO activity was used to
examine the degree of neutrophil infiltration and
inflammation. MPO activity was assessed by
measuring the H2O2-dependent oxidation of
tetramethylbenzidine at 37 ℃ .19 XO activity was
assayed by measuring the increase in absorbance at 292
nm following the formation of uric acid at 30℃.20
Serum serotonin and histamine levels
Serum serotonin was measured by the method of
Shibata et al.21 using HPLC with electrochemical
detection with 0.1 M citric acid/0.1 M sodium acetate
(0.7∶1, v/v) as a mobile phase, and methyl serotonin as
an internal standard. Serum histamine level was
determined by the fluorometric method of Lorenz et
al.22 Histamine was reacted with o-phthalaldehyde (1
mg/mL) and the intensity of the resulting fluorescence
was measured using a spectrofluorometer (Quanti-
Fluor-ST; Promega, Madison, WI, USA; excitation,
360 nm; emission, 460 nm).
Statistical analysis
Data are presented as means ± SD. Statistical analysis
was performed using one-way ANOVA (GraphPad
Prizm Ver. 6, La Jolla, CA, USA) followed by Duncan's
multiple range tests. P < 0.05 was statistically
significant.
RESULTS
Effects of ASLs on gastric mucosal lesion development
The degree of mucosal damage was examined by
histological analysis with PAS and Alcian blue staining
to observe mucus secretion. PAS staining results are
shown in Figure 1. The apical surface of the mucous
cells in normal rats was strongly stained with PAS
(Figure 1A), indicating an intact gastric mucosal layer.
However, PAS reaction was significantly reduced in
surface cells of the control group (Figure 1B), showing
diffusive erosion of the gastric mucosal cell layer in
these rats. PAS reaction was increased in rats treated
with ASLEs (Figure 1C), ASLs (Figure 1D), and
famotidine (Figure 1E) compared with the control
group (Figure 1B), suggesting an increase in mucus
content of the gastric mucosa and alleviation of gastric
Figure 1 Histological analysis of gastric mucosa of rat stained with PAS
A: normal group; B: gastric lesion control group; C: gastric lesion and treated with ASLE; D: gastric lesion and treated with ASLs; E:
gastric lesion positive control group treated with famotidine. Normal group was administered with rat chow. Control group was
administered with chow diet for 5 days and treated with C48/80. ASLE group was administered with hot water extracts of
extruded ASL at 200 mg/kg and treated with C48/80. ASL group was administered with hot water extracts of ASL at 200 mg/kg
and treated with C48/80. Famotidine (4 mg/kg) was treated as a positive control. Surface mucous cells were stained with PAS
strongly. PAS reaction was reduced in surface cells. PAS reaction remained in surface cells. PAS: periodic acid-Schiff; ASLs:
Acanthopanax senticosus var. subinermis leaves. Bar = 200 μm.
A B C D E
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mucosal cell layer erosion. Accordingly, the percentage
of PAS-negative mucosal surface, an index of mucosal
damage, was significantly increased in the gastric lesion
control group compared with the normal group, and
ASL or ASLE treatment normalized the PAS-negative
mucosal surface (Table 1). Extrusion dose-dependently
augmented the effect of ASLs, and ASLEs at 200 mg/
kg exhibited similar percentage PAS-negative surface as
the famotidine-treated group.
A significant decrease in adherent gastric mucus
content was seen in C48/80-treated control rats
compared with normal rats (Table 1). Pre-
administration with ASLs (200 mg/kg) significantly
attenuated the decrease in adherent gastric mucus
content. The effects of ASLEs were greater than those
of ASLs and exhibited dose-dependency. ASLEs at 200
mg/kg normalized the adherent gastric mucus content,
showing similar effects to famotidine treatment.
Effects on gastric oxidative stress
Gastric mucosal MDA content and MPO and XO
activities were significantly increased in C48/80-treated
control rats compared with those of the normal group
(Table 2). The MDA content and MPO and XO
activities in the C48/80-treated control group were
1.6-, 1.5-, and 1.4-fold higher, respectively, than those
in the normal group. ASLs (200 mg/kg) failed to affect
MDA content and MPO activities, whereas XO
activity was significantly decreased by ASL treatment.
However, pre-administered ASLEs dose-dependently
attenuated these parameters, and ASLEs at 200 mg/kg
normalized these parameters, and levels were similar to
those of the famotidine.
Effects on serum serotonin and histamine
Rats treated with C48/80 (control group) showed 2.2-
and 3.8-fold higher serum serotonin and histamine
concentrations, respectively, than in the normal group
(Table 3). Pre-administration of ASLs, ASLEs, or
famotidine significantly reduced serum serotonin and
histamine levels. The extrusion process and dose of
ASLEs did not affect the serum serotonin and
histamine levels.
Effects on Bax and Bcl2 expressions in mucosa
Immunofluorescence staining clearly showed that Bax
was expressed and limited to the cytosol of the gastric
mucosal cells (Figure 2). Bax-positive cells were found
predominantly in the gastric gland of the gastric lesion
control group (Figure 2B). Bax staining in the
submucosa and muscularis externa of the gastric lesion
control group was strongly stained (Figure 2B). Bax
Group
Normal
Control
ASLE-40
ASLE-200
ASL-200
Famotidine
PAS-negative Mucosal surface (%)
20.1±2.9a
33.4±3.6b
27.7±1.7ab
22.2±1.4a
24.4±2.2a
22.0±1.9a
Adherent gastric mucus (% alcian blue/g tissue)
168.3±17.7a
100.0±7.3b
118.1±6.4ab
164.8±21.7a
141.8±14.9a
169.2±15.7a
Notes: normal group was administered with rat chow. Control group was administered with chow diet for 5 days and treated with C48/80.
ASLE-40 and ASLE-200 groups were administered with hot water extracts of extruded ASL at 40 and 200 mg/kg, respectively, and treated
with C48/80. ASL-200 group was administered with hot water extracts of ASL at 200 mg/kg and treated with C48/80. Famotidine:
positive control (4 mg/kg). Samples were orally administered via a stomach tube. Data expressed as means ± SD (n = 10). aP < 0.05 vs
control. bP < 0.05 vs normal. cEffect of extrusion (P < 0.05). ASLs: acanthopanax senticosus var. subinermis leaves.
Table 1 Effects of ASLs on PAS-negative mucosal surface and adherent mucus ( xˉ ± s)
Group
Normal
Control
ASLE-40
ASLE-200
ASL-200
Famotidine
MDA (%)
63.7±7.2b
100.0±16.1a
84.6±5.2a
68.4±10.8bc
113.7±15.8a
65.8±11.3b
MPO (%)
69.0±6.8b
100.0±6.2a
101.3±4.1a
80.6±5.6bc
106.7±4.8a
78.4±5.9b
XO (%)
70.5±6.0b
100.0±17.7a
89.0±8.4a
55.3±8.2ab
57.0±4.2ab
54.7±6.7ab
Notes: normal group was administered with rat chow. Control group was administered with chow diet for 5 days and treated with C48/80.
ASLE-40 and ASLE-200 groups were administered with hot water extracts of extruded ASL at 40 and 200 mg/kg, respectively, and treated
with C48 / 80. ASL-200 group was administered with hot water extracts of ASL at 200 mg/kg and treated with C48 / 80. Famotidine: pos-
itive control (4 mg/kg). Samples were orally administered via a stomach tube. Data expressed as means ± SD (n = 10). aP < 0.05 vs normal.
bP < 0.05 vs control. cEffect of extrusion (P < 0.05). ASLs: Acanthopanax senticosus var. subinermis leaves; MDA: malondialdehyde; MPO:
myeloperoxidase; XO: xanthine oxidase.
Table 2 Effects of ASLs on gastric mucosal MDA content, and MPO, and XO activity ( xˉ ± s)
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staining was decreased in the ASLE-, ASL- and
famotidine-treated rats (Figure 2C, D and E,
respectively) compared with the control group (Figure
2B), suggesting alleviation of gastric mucosal cell
apoptotic damage. Total Bax expression was
significantly increased in the gastric lesion control
group, and ASL, ASLE or famotidine administration
normalized Bax expression. The effects of ASLEs were
greater than those of ASLs. In contrast, Bcl-2-positive
cells were found predominantly in the gastric gland
(Figure 3A). Bcl-2 staining in the submucosa and
muscularis externa was strongly stained in the normal
group (Figure 3A), but was absent in the gastric
mucosa and submucosa of the gastric lesion control
rats (Figure 3B). ASLEs, ASLs and famotidine
recovered Bcl-2 staining in the gastric mucosa and
submucosa (Figure 3C, D and E, respectively). Total
expression of Bcl-2 was markedly decreased in the C48/
80-treated group and increased by ASL, ASLE or
famotidine administration. Likewise, extrusion
enhanced the effect on Bcl-2 expression.
Effects on Bax and Bcl-2 western blotting in mucosa
The gastric gland, submucosa, and muscularis externa
were microdissected (Figure 4A). Proteins were
extracted, and the expression of Bax and Bcl-2 protein
was determined by western blotting. Bax protein was
increased in the C48/80-treated controls and decreased
in the ASL- and famotidine-treated groups. In
contrast, Bcl-2 protein expression was decreased in
C48/80-treated controls and increased in the ASL- and
famotidine-treated groups (Figure 4B). Extrusion
augmented the effects of ASLs on Bax and Bcl-2
expression. The ratio of Bax and Bcl-2 significantly
increased in the gastric lesion control group compared
with the normal group (Figure 4C, P < 0.05). ASL and
ASLE treatment significantly decreased Bax/Bcl-2
ratios similar to famotidine treatment, compared with
the gastric lesion control group (P < 0.05).
DISCUSSION
The results of the present study clearly show that ASLs
administered orally to C48/80-treated rats protect
against the progression of gastric mucosal lesions, and
the preventive effect of ASLs is augmented by
extrusion. ASLEs demonstrated protective effects by
increasing gastric mucus secretion, as assessed by PAS
staining and Alcian blue binding to gastric mucus. The
wide distribution of adherent mucus content in the
gastrointestinal tract plays a pivotal role in cyto-
protection and repair of the gastric mucosa.23 Mucus
secretion is a crucial factor in protection against gastric
mucosal lesions and is regarded as an important
defensive factor in the gastric mucus barrier, and a
decrease in the synthesis of mucus is implicated in the
etiology of gastric ulcer.24 The mucus layer protects the
newly formed cells against damage caused by acidic pH
and the proteolytic potential of gastric secretions.25
The results of the present study showed that severity of
erosion induced by C48/80 treatment was alleviated by
ASL and ASLE administration, and gastric mucosal
damage and mucus secretion assessed by PAS-negative
mucosal surface and Alcian blue staining were
dose-dependently improved by ASLE administration.
These results indicate that the gastroprotective effect of
ASLEs was mediated partly by preservation of the
gastric mucus secretion and reinforcement of the
mucosal barrier. The effects of ASLEs at 200 mg/kg
were similar to those of famotidine, a histamine
H2-receptor antagonist that inhibits gastric acid
production, which is widely used in gastric ulcer.
Neutrophils are a major source of inflammatory
mediators and can release potent reactive oxygen
species (ROS) such as superoxide, H2O2, and
MPO-derived oxidants resulting in lipid
peroxidation.26 Ohta et al.15 suggested that neutrophil
infiltration plays a critical role in C48/80-induced
acute gastric mucosal lesion formation and
progression. Similarly, Abulla et al.27 demonstrated that
the reduction of neutrophil infiltration into ulcerated
gastric tissues helped to prevent gastric ulcers in rats. In
the present study, ASLE administration (200 mg/kg)
normalized the increased gastric mucosal neutrophil
infiltration of C48/80-treated rats assessed by MPO
activity. The level of MPO activity is directly
proportional to the number of neutrophils, and
Krawisz et al.28 suggested that MPO activity can be
used to quantitate inflammation. Therefore, the results
of the present study suggest the suppressive effect on
neutrophil infiltration and anti-inflammatory action of
ASLE.
Group
Normal
Control
ASLE-40
ASLE-200
ASL-200
Famotidine
Serotonin (nmol/L)
5.5±0.5b
12.2±1.1a
8.9±0.9ab
8.5±0.7ab
9.1±0.9ab
8.6±0.8ab
Histamine (nmol/L)
0.4±0.1b
1.5±0.5a
0.8±0.2ab
0.7±0.2ab
0.7±0.2ab
0.6±0.3b
Notes: normal group was administered with rat chow. Control
group was administered with chow diet for 5 days and treated
with C48/80. ASLE-40 and ASLE-200 groups were
administered with hot water extracts of extruded ASL at 40 and
200 mg/kg, respectively, and treated with C48 / 80. ASL-200
group was administered with hot water extracts of ASL at 200
mg/kg and treated with C48 / 80. Famotidine: positive control
(4 mg/kg). Samples were orally administered via a stomach tube.
ASLs: Acanthopanax senticosus var. subinermis leaves. Data
expressed as means ± SD (n = 10). aP < 0.05 vs normal. bP < 0.05
vs control.
Table 3 Effects of Acanthopanax senticosus var. subinermis
leaves (ASLs) on serum serotonin and histamine levels ( xˉ
± s)
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counterstain (red). A-E: Immunofluorescence analysis of Bax in gastric
mucosa (× 400). A1-A4: normal group; B1-B4: gastric lesion control group;
C1-C4: gastric lesion treated with ASLE; D1-D4: gastric lesion treated with
ASL; E1-E4: gastric lesion positive control group treatedwith famotidine. A1,
B1, C1,D1, E1: bax;A2, B2, C2,D2, E2: Propidium iodide;A3, B3, C3,D3, E3:DIC
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extruded ASL (ASLE) at 200mg/kg and treatedwith C48/ 80. ASL groupwas
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C48/ 80. Famotidine group was treated with famotidine (4 mg/kg) and
treated with C48/ 80. F: Bax expression. aP < 0.05 vs normal. bP < 0.05 vs
control. cEffect of extrusion (P < 0.05). ASLs: Acanthopanax senticosus var.
subinermis leaves; DIC: differential interference contrast.
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Figure 3 Analysis of Bcl-2 in the gastric mucosa
Bcl-2-positive cells were probed with anti-Bcl-2 monoclonal antibody in rat
gastric mucosa. Anti-IgG immunofluorescence (green); propidium iodide
counterstain (red). A-E: Immunofluorescence analysis of Bcl-2 in the gastric
mucosa (× 400). A1-A4: normal group; B1-B4: gastric lesion control group;
C1-C4: gastric lesion treated with ASLE; D1-D4: gastric lesion treated with ASL;
E1-E4: gastric lesion positive control group treated with famotidine. A1, B1, C1,
D1, E1: bcl-2; A2, B2, C2,D2, E2: Propidium iodide; A3, B3, C3,D3, E3:DIC image; A4,
B4, C4, D4, E4: Merge. Normal group was administered with rat chow. Control
group was administered with chow diet for 5 days and treated with C48/80.
ASLE group was administered with hot water extracts of extruded ASL at 200
mg/kg and treated with C48/80. ASL group was administered with hot water
extracts of ASL at 200 mg/kg and treated with C48/80. Famotidine (4 mg/kg)
was treated as a positive control. F: bcl-2 expression. aP < 0.05 vs normal. bP <
0.05 vs control. cEffect of extrusion (P < 0.05). ASLs: Acanthopanax senticosus
var. subinermis leaves; DIC: differential interference contrast.
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It has been shown that changes in gastric mucosal ROS
metabolism and neutrophil infiltration into gastric
mucosal tissues are closely related to the development
of gastric mucosal lesions in rats with a single C48/80
treatment.14 XO generates ROS during the oxidation of
hypoxanthine or xanthine,29 and Ohta et al.30 suggested
that the xanthine-XO system in the gastric mucosal
tissue participates in the progression of gastric mucosal
lesions. In the present study, increased MPO activity,
an index of neutrophil infiltration, was reduced in the
gastric lesion control group, and ROS-related
parameters such as MDA content and XO activity
were normalized by 200 mg/kg ASLEs. From the
present study, it seems likely that administration of
ASLEs exerts a preventive effect on the progression of
C48/80-induced acute gastric mucosal lesions, by
protecting the gastric mucosal barrier and tissue against
attack from ROS derived from infiltrated neutrophils
and the xanthine-XO system, through preservation of
gastric mucus.
It has been demonstrated that histamine released from
degranulated connective tissue mast cells contributes to
the development of gastric mucosal lesions in rats
treated once with C48/80.14,31 We observed that the
increased serum histamine levels induced by C48/80
treatment were attenuated by ASLs or ASLEs. This
result indicates that the preventive effect of ASLs and
ASLEs is due to the preventive effect of gastric mast
cell degranulation caused by C48/80 and the release of
histamine from degranulated mast cells.
It is reported that apoptosis is one of the main factors
that contributes to gastric ulcer formation.32 The
normal physiological state of gastric mucosa is always
under equilibrium between the cell death and cell
renewal processes, and gastric lesions develop when
there is an increase in apoptosis and/or inhibition of
cell proliferation.33 The Bcl-2 family of proteins are the
main organizers of apoptotic cell death, where Bcl-2
protein inhibits apoptosis and Bax protein promotes
apoptosis.32 In many experimental ulcer models,
apoptosis results from the alteration of Bcl-2
anti-apoptotic and Bax pro-apoptotic expression.32,34 In
the present study, the predominant increase in Bax
expression was observed after C48/80-induced acute
gastritis. In contrast to Bax, Bcl-2 expression was
decreased after C48/80-induced acute gastritis,
indicating increased apoptotic activity in gastric
mucosal tissues by C48/80 treatment. The increased
Bax expression and decreased Bcl-2 expression induced
by C48/80 treatment were attenuated by ASLs and
these effects were enhanced by the extrusion process.
All these positive effects are likely to interact with
certain components in ASLs, such as saponins and
flavonoids. Saponins and flavonoids in ASLs have
potent anti-oxidant activity.5,35 In fact, these
compounds also act as anti-inflammatory agents.5
Furthermore, it is suggested that the extrusion process
increases the polyphenolic composition and
anti-oxidant capacity.13
The results of the present study indicate that ASLs
exerted a preventive effect on the progression of C48/
80-induced acute gastric mucosal lesions in rats,
possibly by inducing mucus secretion, and attenuating
enhanced neutrophil infiltration and inflammation,
and oxidative stress in gastric mucosa. Moreover, ASLs
showed anti-apoptotic activity, demonstrated by
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Figure 4 Western blotting analysis of
Bax and Bcl-2
The regions of interest were identified
with LMD (A1, Before), cut away with a
near-IR laser (A2, Cutting), and
dropped away from the tissue (A3,
After). B: Western blotting showed
changes in the expression levels of
Bax and Bcl-2 in the microdissected
gastric tissue. Bax; 21 kDa, Bcl-2; 26
kDa of Western blotting. C:
Densitometric results of the relative
changes in the expression levels of
Bax and Bcl-2. Original magnification×
400. LMD：laser micro-dissection. aP <
0.05 vs normal. bP < 0.05 vs control.
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down-regulation of Bax protein and up-regulation of
Bcl-2 expression. The effects of ASLs were significantly
enhanced by the extrusion process.
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